2023 annual financial data
Coya Therapeutics 2023 Net margin
Direct answer
Net margin was -133.08%.
Operating income was -7,903,349 USD and net income was -7,987,836 USD.
Operating cash flow was -11,188,811 USD.
Get free Coya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,002,206 USD
- Operating income
- -7,903,349 USD
- Net income
- -7,987,836 USD
- Operating cash flow
- -11,188,811 USD